Psoriasis Clinical Trial

Regulation of Inflammatory Genes in Psoriasis

Summary

Psoriasis is a chronic and recurrent skin disorder characterized by marked inflammatory changes in the skin. An extensive cytokine network including generated by activated dendritic cells and T cells mediates the formation of psoriatic lesions. These immune-response parameters can be used as markers in the severity and management of the disease after further in-depth studies.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Clinical diagnosis of psoriasis
Must be age 19 or older.
Must be Fitzpatrick skin type I, II, III, IV, V, VI.

Exclusion Criteria:

Subjects who do not have photosensitive disease and are not on photosensitizing medications.
Subjects with a history of keloids (who are more likely to develop hypertrophic scars following skin biopsy).
Subjects who have an allergy to local anesthetics, antibiotics and/or anticoagulants.
Subjects who are pregnant.

Study is for people with:

Psoriasis

Estimated Enrollment:

13

Study ID:

NCT03125655

Recruitment Status:

Recruiting

Sponsor:

University of Alabama at Birmingham

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

The Kirklin Clinic
Birmingham Alabama, 35294, United States More Info
Wendy Cantrell
Contact
205-502-9960
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Psoriasis

Estimated Enrollment:

13

Study ID:

NCT03125655

Recruitment Status:

Recruiting

Sponsor:


University of Alabama at Birmingham

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.